These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34310654)

  • 21. Management of Left Ventricular Thrombi with Direct Oral Anticoagulants: Retrospective Comparative Study with Vitamin K Antagonists.
    Daher J; Da Costa A; Hilaire C; Ferreira T; Pierrard R; Guichard JB; Romeyer C; Isaaz K
    Clin Drug Investig; 2020 Apr; 40(4):343-353. PubMed ID: 32144651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in patients with left ventricular thrombus: A meta-analysis.
    Zhou K; Zhang X; Xiao Y; Li D; Song G
    Thromb Res; 2021 Jan; 197():185-191. PubMed ID: 33227655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis.
    Hu T; Li YH; Han WQ; Maduray K; Chen TS; Hao L; Zhong JQ
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):683-694. PubMed ID: 37639201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis comparing direct oral anticoagulants versus vitamin K antagonists in patients with left ventricular thrombus.
    Kido K; Ghaffar YA; Lee JC; Bianco C; Shimizu M; Shiga T; Hashiguchi M
    PLoS One; 2021; 16(6):e0252549. PubMed ID: 34086768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the safety and efficacy of direct oral anticoagulants compared with vitamin-k antagonists in the treatment of left ventricular thrombosis. A systematic review and meta-analysis.
    Mehrpooya M; Barakzehi MR; Nikoobakhsh M
    Heart Lung; 2024; 67():121-136. PubMed ID: 38754272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct oral anticoagulants to treat left ventricular thrombus-A systematic review and meta-analysis: ELECTRAM investigators.
    Shah S; Shah K; Turagam MK; Sharma A; Natale A; Lakkireddy D; Garg J
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1764-1771. PubMed ID: 33772939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of direct oral anticoagulants versus vitamin K antagonists or warfarin in patients with left ventricular thrombus outcomes: A systematic review and meta-analysis.
    da Silva Ferreira H; Lima Lopes J; Augusto J; Simões J; Roque D; Faria D; Ferreira J; Fialho I; Beringuilho M; Morais H; Ferreira AR; Morais J; Morais C
    Rev Port Cardiol; 2023 Jan; 42(1):63-70. PubMed ID: 36370988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data.
    Cochran JM; Jia X; Kaczmarek J; Staggers KA; Rifai MA; Hamzeh IR; Birnbaum Y
    J Cardiovasc Pharmacol Ther; 2021 Mar; 26(2):173-178. PubMed ID: 33078629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The efficacy and safety of direct oral anticoagulants versus vitamin K antagonists in patients with left-sided bioprosthetic heart valves and atrial fibrillation: a systematic review and meta-analysis.
    Li D; Chang P; Zhang H; Bai F; Wu Q
    Eur J Clin Pharmacol; 2023 Apr; 79(4):461-471. PubMed ID: 36795127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials.
    de Lucena LA; Freitas MAA; Souza AKC; Silva CHA; Watanabe JMF; Guedes FL; Almeida JB; de Oliveira RA
    J Thromb Thrombolysis; 2024 Mar; 57(3):381-389. PubMed ID: 38281231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct Oral Anticoagulants versus Vitamin K Antagonists for the Treatment of Left Ventricular Thrombosis: A Meta-Analysis.
    Li J; Hu Y; Wu Z
    Rev Cardiovasc Med; 2022 Sep; 23(9):312. PubMed ID: 39077723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation for the Treatment of Cancer-Associated Thrombosis: A Systematic Review and Network Meta-Analysis of Randomized Trials.
    Sobieraj DM; Baker WL; Smith E; Sasiela K; Trexler SE; Kim O; Coleman CI
    Clin Appl Thromb Hemost; 2018 Dec; 24(9_suppl):182S-187S. PubMed ID: 30244595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of direct oral anticoagulants vs vitamin K antagonists in patients with atrial fibrillation and end-stage renal disease on hemodialysis: A systematic review and meta-analysis.
    Kyriakoulis I; Adamou A; Stamatiou I; Chlorogiannis DD; Kardoutsos I; Koukousaki D; Ntaios G
    Eur J Intern Med; 2024 Jan; 119():45-52. PubMed ID: 37648582
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DOACs Versus VKAs in Older Adults Treated for Acute Venous Thromboembolism: Systematic Review and Meta-Analysis.
    Chaudhary R; Pagali S; Garg J; Murad MH; Wysokinski WE; McBane RD
    J Am Geriatr Soc; 2020 Sep; 68(9):2021-2026. PubMed ID: 32441334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Benefit of Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves.
    Russo V; Carbone A; Attena E; Rago A; Mazzone C; Proietti R; Parisi V; Scotti A; Nigro G; Golino P; D'Onofrio A
    Clin Ther; 2019 Dec; 41(12):2549-2557. PubMed ID: 31735436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Oral Anticoagulation Versus Warfarin in Left Ventricular Thrombus: Pooled Analysis of Randomized Controlled Trials.
    Sahlén AO; Jiang H; Lau YH; Cuenza L; Cader FA; Al-Omary M; Surunchupakorn P; Ho KH; Sung J; Lee D; Honda S; Tan Wei Chieh J; Yap J
    J Clin Pharmacol; 2023 Oct; 63(10):1101-1107. PubMed ID: 37139934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct Oral Anticoagulant for the Treatment of VTE in Cancer Patients: A Systematic Review and Meta-analysis.
    Dong S; Zhang Y; Li Y; Li Y; Miao Y; Zhao R; Zhai S
    Ann Pharmacother; 2021 Apr; 55(4):430-439. PubMed ID: 32938202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials.
    Khairani CD; Bejjani A; Piazza G; Jimenez D; Monreal M; Chatterjee S; Pengo V; Woller SC; Cortes-Hernandez J; Connors JM; Kanthi Y; Krumholz HM; Middeldorp S; Falanga A; Cushman M; Goldhaber SZ; Garcia DA; Bikdeli B
    J Am Coll Cardiol; 2023 Jan; 81(1):16-30. PubMed ID: 36328154
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significant Benefit of Uninterrupted DOACs Versus VKA During Catheter Ablation of Atrial Fibrillation.
    Romero J; Cerrud-Rodriguez RC; Alviz I; Diaz JC; Rodriguez D; Arshad S; Cerna L; Taveras J; Grupposo V; Natale A; Garcia M; Di Biase L
    JACC Clin Electrophysiol; 2019 Dec; 5(12):1396-1405. PubMed ID: 31857038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients Undergoing Cardioversion for Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Gupta S; Um KJ; Pandey A; McIntyre WF; Ivanova M; Allahverdi Y; Agahi P; Pandya F; Lopez A; Sachdeva A; Whitlock RP; Belley-Cote EP
    Cardiovasc Drugs Ther; 2019 Jun; 33(3):339-352. PubMed ID: 31011880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.